Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
Wenhua Sang, Yiduo Zhou, Haiyan Chen, et al.
Cancer Discovery (2023) Vol. 14, Iss. 2, pp. 326-347
Closed Access | Times Cited: 21

Showing 21 citing articles:

The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 70
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Targeting MHC-I inhibitory pathways for cancer immunotherapy
Jun Wang, Lu Qiao, Xufeng Chen, et al.
Trends in Immunology (2024) Vol. 45, Iss. 3, pp. 177-187
Closed Access | Times Cited: 12
CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications
Xiaohang Feng, Z Y Li, Yuping Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
CASC8 activates the pentose phosphate pathway to inhibit disulfidptosis in pancreatic ductal adenocarcinoma though the c-Myc-GLUT1 axis
Hong-Fei Yao, Jieqiong Ge, Jiahao Chen, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer
Yi Zhou, Huali Li, Yaxin Zhang, et al.
Cancer Letters (2024) Vol. 589, pp. 216836-216836
Open Access | Times Cited: 6
CRISPR/Cas9 screening: unraveling cancer immunotherapy’s ‘Rosetta Stone’
Baoxiang Chen, Yanrong Deng, Xianghai Ren, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 736-749
Open Access | Times Cited: 4
CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment
Haiyan Xu, Shengbai Xue, Yang Sun, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010029-e010029
Open Access
Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell axis in MHC-I deficient pancreatic cancer
Zhuozhuo Wu, Qungang Shan, Yuyue Jiang, et al.
Cancer Letters (2025), pp. 217620-217620
Closed Access
Autophagy in tumor immune escape and immunotherapy
Huan Wang, Peng Sun, Xijing Yuan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
RIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitination
Lu Chen, Hongda Liu, Tianyu Liu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
B4GALT5 inhibits CD8+T-cell response by downregulating MHC-I level through ERAD pathway in PDAC
Xin Xing, Shi-Qi Yin, Xiaqing Li, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 5, pp. e010908-e010908
Open Access
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies
Sravani Ramisetty, Ayalur Raghu Subbalakshmi, Siddhika Pareek, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3337-3337
Open Access | Times Cited: 2
Targeting the MHC-I endosomal-lysosomal trafficking pathway in cancer: From mechanism to immunotherapy
Di Ye, Shuang Zhou, Xinyu Dai, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189161-189161
Closed Access | Times Cited: 2
High-throughput screening for optimizing adoptive T cell therapies
Yuchen Zhang, Qinglong Xu, Zhifei Gao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
A multi-subunit autophagic capture complex facilitates degradation of ER stalled MHC-I in pancreatic cancer.
Marine Berquez, Alexander Li, Matthew Luy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
PROTAC delivery in tumor immunotherapy: Where are we and where are we going?
Yiyang Li, Yike Wu, Shugeng Gao, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 116-144
Closed Access | Times Cited: 1
Molecular mechanism of pancreatic ductal adenocarcinoma: The heterogeneity of cancer-associated fibroblasts and key signaling pathways
Zhongyuan Hu, Ding Ding, Yu Song, et al.
World Journal of Clinical Oncology (2024) Vol. 16, Iss. 2
Closed Access | Times Cited: 1
Mechanisms of Low MHC I Expression and Strategies for Targeting MHC I with Small Molecules in Cancer Immunotherapy
S. W. Kong, Jie Zhang, Longsheng Wang, et al.
Cancer Letters (2024) Vol. 611, pp. 217432-217432
Closed Access | Times Cited: 1
“RIPping” off Pancreas Cancer's Blockage of Immune Surveillance
Xiuting Liu, Blake Sells, David G. DeNardo
Cancer Discovery (2024) Vol. 14, Iss. 2, pp. 208-210
Closed Access
Single-cell and spatial transcriptomic analyses reveal the cellular origins and drivers of liver metastasis from pancreatic cancer
Jing Cui, Yao Guo, Taoyu Chen, et al.
Research Square (Research Square) (2024)
Open Access
RIPK4 driven by TP53 mutations promotes resistance to redox stress of CRC by phosphorylating MTHFD1
Long Yu, Sha Zhou, Yanbo Xu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top